{"id":"https://openalex.org/W2286774571","doi":"https://doi.org/10.1126/scitranslmed.aad6913","title":"Buying cures versus renting health: Financing health care with consumer loans","display_name":"Buying cures versus renting health: Financing health care with consumer loans","publication_year":2016,"publication_date":"2016-02-24","ids":{"openalex":"https://openalex.org/W2286774571","doi":"https://doi.org/10.1126/scitranslmed.aad6913","mag":"2286774571","pmid":"https://pubmed.ncbi.nlm.nih.gov/26912902"},"language":"en","primary_location":{"id":"doi:10.1126/scitranslmed.aad6913","doi":"https://doi.org/10.1126/scitranslmed.aad6913","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scitranslmed.aad6913","pdf_url":null,"source":{"id":"https://openalex.org/S24207032","display_name":"Science Translational Medicine","issn_l":"1946-6234","issn":["1946-6234","1946-6242"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Translational Medicine","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030404346","display_name":"Vahid Montazerhodjat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vahid Montazerhodjat","raw_affiliation_strings":["MIT Department of Electrical Engineering and Computer Science, Cambridge, MA, USA","MIT Laboratory for Financial Engineering, Sloan School of Management, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Department of Electrical Engineering and Computer Science, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]},{"raw_affiliation_string":"MIT Laboratory for Financial Engineering, Sloan School of Management, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David M. Weinstock","raw_affiliation_strings":["Broad Institute of Harvard and MIT, Cambridge, MA, USA","Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of Harvard and MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109980718","display_name":"Andrew W. Lo","orcid":"https://orcid.org/0000-0003-2944-7773","observed_orcids":["https://orcid.org/0000-0003-2944-7773"]},"institutions":[{"id":"https://openalex.org/I4405258931","display_name":"MIT Computer Science and Artificial Intelligence Laboratory","ror":"https://ror.org/01e85r662","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405258931","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew W. Lo","raw_affiliation_strings":["AlphaSimplex Group LLC, Cambridge, MA, USA","MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA","MIT Department of Electrical Engineering and Computer Science, Cambridge, MA, USA","MIT Laboratory for Financial Engineering, Sloan School of Management, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AlphaSimplex Group LLC, Cambridge, MA, USA","institution_ids":[]},{"raw_affiliation_string":"MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405258931"]},{"raw_affiliation_string":"MIT Department of Electrical Engineering and Computer Science, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]},{"raw_affiliation_string":"MIT Laboratory for Financial Engineering, Sloan School of Management, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5026688095","https://openalex.org/A5109980718"],"corresponding_institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4405258931","https://openalex.org/I63966007"],"apc_list":null,"apc_paid":null,"fwci":1.6246,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.83160083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"8","issue":"327","first_page":"327ps6","last_page":"327ps6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.051500000059604645,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/health-care-financing","display_name":"health care financing","score":0.7020000219345093},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.7559999823570251},{"id":"https://openalex.org/keywords/securitization","display_name":"securitization","score":0.8059999942779541},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.48500001430511475},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.8209999799728394},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.996999979019165},{"id":"https://openalex.org/keywords/single-payer-health-care","display_name":"single-payer health care","score":0.878000020980835},{"id":"https://openalex.org/keywords/pharmaceutical-industry-incentives","display_name":"pharmaceutical industry incentives","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.6754711270332336},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6690173149108887},{"id":"https://openalex.org/C70587473","wikidata":"https://www.wikidata.org/wiki/Q7834111","display_name":"Transformative learning","level":2,"score":0.6332279443740845},{"id":"https://openalex.org/C85502023","wikidata":"https://www.wikidata.org/wiki/Q157171","display_name":"Renting","level":2,"score":0.6220834255218506},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.5379287600517273},{"id":"https://openalex.org/C2992054633","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health care financing","level":3,"score":0.47693580389022827},{"id":"https://openalex.org/C2992052470","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Medical expenses","level":2,"score":0.4565559923648834},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.38748276233673096},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29130327701568604},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.15834686160087585},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.15097865462303162},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.11797276139259338},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.11499300599098206},{"id":"https://openalex.org/C19417346","wikidata":"https://www.wikidata.org/wiki/Q7922","display_name":"Pedagogy","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003695","descriptor_name":"Delivery of Health Care","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D005376","descriptor_name":"Financial Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007348","descriptor_name":"Insurance, Health","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D009042","descriptor_name":"Motivation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1126/scitranslmed.aad6913","doi":"https://doi.org/10.1126/scitranslmed.aad6913","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scitranslmed.aad6913","pdf_url":null,"source":{"id":"https://openalex.org/S24207032","display_name":"Science Translational Medicine","issn_l":"1946-6234","issn":["1946-6234","1946-6242"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Translational Medicine","raw_type":"journal-article"},{"id":"pmid:26912902","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26912902","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science translational medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W632983329","https://openalex.org/W1980154502","https://openalex.org/W2012670419","https://openalex.org/W2036913245","https://openalex.org/W2048509646","https://openalex.org/W2057085976","https://openalex.org/W2060565181","https://openalex.org/W2060918723","https://openalex.org/W2063660545","https://openalex.org/W2078251659","https://openalex.org/W2081689022","https://openalex.org/W2082359945","https://openalex.org/W2133036275","https://openalex.org/W2143850932","https://openalex.org/W2153720399","https://openalex.org/W2170510737","https://openalex.org/W2170706646","https://openalex.org/W2795413297","https://openalex.org/W2916906760","https://openalex.org/W3010973940","https://openalex.org/W3023171975","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2414924926","https://openalex.org/W2793426955","https://openalex.org/W4229373016","https://openalex.org/W4220909299","https://openalex.org/W2964334807","https://openalex.org/W4408625323","https://openalex.org/W2766700667","https://openalex.org/W2774924171","https://openalex.org/W2164902648","https://openalex.org/W2530126860"],"abstract_inverted_index":{"A":[0],"crisis":[1],"is":[2,23,135],"building":[3],"over":[4],"the":[5,94,110,160,166],"prices":[6],"of":[7,49,70,96,112,123,141,162],"new":[8],"transformative":[9,97,155],"therapies":[10,27,98,156],"for":[11,51,137],"cancer,":[12],"hepatitis":[13],"C":[14],"virus":[15],"infection,":[16],"and":[17,30,62,86,128,144,165],"rare":[18],"diseases.":[19],"The":[20],"clinical":[21,84],"imperative":[22],"to":[24,39,65,83,153],"offer":[25,103],"these":[26],"as":[28,32],"broadly":[29],"rapidly":[31],"possible.":[33],"We":[34],"propose":[35,109],"a":[36,67,119,138,148],"practical":[37],"way":[38],"increase":[40],"drug":[41],"affordability":[42],"through":[43,125],"health":[44,53],"care":[45,54],"loans":[46],"(HCLs)-the":[47],"equivalent":[48],"mortgages":[50],"large":[52,120],"expenses.":[55],"HCLs":[56,79,124],"allow":[57],"patients":[58],"in":[59],"both":[60,126],"multipayer":[61],"single-payer":[63],"markets":[64],"access":[66,154],"broader":[68,150],"set":[69],"therapeutics,":[71],"including":[72],"expensive":[73],"short-duration":[74],"treatments":[75],"that":[76,102,133],"are":[77],"curative.":[78],"also":[80,158],"link":[81],"payment":[82],"benefit":[85],"should":[87],"help":[88],"lower":[89],"per-patient":[90],"cost":[91,145],"while":[92,157],"incentivizing":[93],"development":[95],"rather":[99],"than":[100],"those":[101],"small":[104],"incremental":[105],"advances.":[106],"Moreover,":[107],"we":[108],"use":[111],"securitization-a":[113],"well-known":[114],"financial":[115],"engineering":[116],"method-to":[117],"finance":[118],"diversified":[121],"pool":[122],"debt":[127],"equity.":[129],"Numerical":[130],"simulations":[131],"suggest":[132],"securitization":[134],"viable":[136],"wide":[139],"range":[140],"economic":[142],"environments":[143],"parameters,":[146],"allowing":[147],"much":[149],"patient":[151],"population":[152],"aligning":[159],"interests":[161],"patients,":[163],"payers,":[164],"pharmaceutical":[167],"industry.":[168]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}